Jessie Ann Flaim-Spetsas

Jessie Ann Flaim-Spetsas currently serves as the Director of Clinical Quality and Risk Management at ADC Therapeutics since September 2024. Prior to this role, Jessie held the position of Director, Clinical Quality at IN8bio from November 2022 to September 2024. From October 2011 to November 2022, Jessie worked as Clinical Research/QA at Precision for Medicine Oncology and Rare Disease (formerly ACT Oncology). Educationally, Jessie obtained a certification in Radiation Therapy from Gwynedd Mercy University, accumulating 32 credits, and earned an Associates in Science with a Certificate Program in Radiology from Fairleigh Dickinson University, with a total of 95 credits.